Commercial & Market Access Strategy for a Prescription Digital Therapeutic (PDT) in Migraine

A digital therapeutics company developing a PDT for migraines sought to understand optimal product positioning within the market, go-to-market (GTM) options, expected revenue, launch activities, and define evidence generation and payer engagement strategies.

We began by assessing the migraine landscape, leveraging primary and secondary research as well as claims data. This helped us to determine the optimal product positioning. It also enabled us to build an 18-scenario revenue forecast. In the next phase of our work, we constructed a payer value story and high-level evidence generation plan. This work was informed by secondary research, primary research, analogue analysis, and our own expertise in payer attitudes towards digital health products. Finally, we provided a launch planning framework that included a list of expected launch activities across functions, estimated timelines, and resourcing needs for launch execution.

Our work identified two prioritized product use cases and an overarching launch approach. The client also received an accompanying forecast and an organized presentation of market insights to inform further commercial strategy development.